Back to search

Article

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the Field

2026-03-02

Abstract excerpt

Tumor heterogeneity and microenvironmental complexity remain fundamental barri-ers to genomics-centered precision oncology, frequently causing discordance between molecular alterations and real-world therapeutic responses. Here, we reviewed pa-tient-derived organoid (PDO) technologies as functional platforms that complement molecular profiling by directly investigating patient-specific sensitivity, resistance, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
edf419a9-3c10-5cb5-a305-e6d439f22489
DOI
10.20944/preprints202603.0100.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldDOI 10.20944/preprints202603.0100.v1
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.Semantic proximity
Functional precision oncology using patient-derived assays: bridging genotype and phenotype.Semantic proximity
Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current OpportunitiesSemantic proximity
The application of organoids in treatment decision-making for digestive system cancers: progress and challengesSemantic proximity
Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncologySemantic proximity
Optimized large-scale longitudinal biorepository of gastroesophageal adenocarcinoma patient-derived organoids: High-fidelity models for personalized treatment to overcome resistanceSemantic proximity
From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ-on-a-Chip in Colorectal Cancer.Semantic proximity
Pan-Cancer PDOs Preserve Tumor Heterogeneity and Uncover Therapeutic VulnerabilitiesSemantic proximity
Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy ResponseSemantic proximity
A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoidsSemantic proximity
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivitySemantic proximity
Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumorsSemantic proximity
Select a neighboring publication to make it the new centre.